Providence First Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Providence First Trust's PFE Position: Q4 2025 in Review
Providence First Trust sold out of Pfizer (PFE) in Q4 2025, closing a stake of 12,602 shares — an estimated $321K sold.
Providence First Trust first reported a position in PFE in Q1 2022 and held it in 15 quarters. The position peaked at $651K in Q2 2022. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Providence First Trust reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Providence First Trust sold 12,602 Pfizer shares in Q4 2025, an estimated $321K.
- Providence First Trust first reported a position in Pfizer in Q1 2022 and held it in 15 quarters.
- Providence First Trust's Pfizer position peaked at $651K in Q2 2022.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Providence First Trust's 13F filing for Q4 2025, filed 3 Feb 2026.